SCHEMBL30863427

SCHEMBL30863427

COc1ccc(NC(=O)c2ccc(C3CCN(C)CC3)cc2)c2ccncc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC1 Q13547 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52
▸ HDAC2 Q92769 1/20 0.52
▸ HDAC10 Q969S8 1/20 0.52
▸ HDAC11 Q96DB2 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ HDAC9 Q9UKV0 1/20 0.52
▸ HDAC5 Q9UQL6 1/20 0.52
▸ FGFR1 P11362 2/20 0.47
▸ MCHR1 Q99705 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ KDM1A O60341 2/20 0.46
▸ MAOA P21397 2/20 0.46
▸ KDM1B Q8NB78 2/20 0.46
▸ RCOR1 Q9UKL0 2/20 0.46
▸ EGFR P00533 1/20 0.43
▸ CCR5 P51681 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195717 0.86 HDAC1 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27195718 0.85 HDAC1 (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL30863442 0.83 NPC1 (0.54) HDAC3HDAC8
SCHEMBL30863460 0.82 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27195713 0.81 HDAC6 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27195711 0.81 HDAC6 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30863527 0.81 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30863451 0.81 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30863383 0.77 PDE4D (0.52) PDE4APDE4BPDE4CPDE4DGSK3A
SCHEMBL30863478 0.77 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP claimed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO claimed
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
Send feedback